Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 4”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02032888
What this trial is testing

Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 238
Large-scale testing (Phase 3)Study completedNCT00158496
What this trial is testing

Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)

Who this might be right for
Chronic Hepatitis C
French National Agency for Research on AIDS and Viral Hepatitis 100
Large-scale testing (Phase 3)Study completedNCT03080415
What this trial is testing

Treatment of Egyptian Hepatitis C Genotype 4 Infected Children (and Adolescents) With Combined Sofosbuvir & Daclatasvir

Who this might be right for
Hepatitis C Genotype 4
Yassin Abdelghaffar Charity Center for Liver Disease and Research 40
Testing effectiveness (Phase 2)Study completedNCT01132313
What this trial is testing

Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 488
Large-scale testing (Phase 3)Study completedNCT04387526
What this trial is testing

Sofosbuvir Plus Daclatasvir With or Without Ribavirin and Chronic HCV Genotype (GT) 4

Who this might be right for
Chronic Hepatitis C Virus Infection
Beni-Suef University 946
Large-scale testing (Phase 3)Study completedNCT03578640
What this trial is testing

Eight Weeks of Elbasvir/Grazoprevir in the Treatment of HCV Genotype 4

Who this might be right for
Hepatitis C, Chronic
King Fahad Medical City 30
Not applicableUnknownNCT02507882
What this trial is testing

Impact of IL-28B rs12979860 and rs4803217 Gene Polymorphisms Associated With miRNAs Deregulation on HCV-related Hepatocellular Carcinoma

Who this might be right for
HCV Infection ( Genotype 4)
Dr.Waleed Samir 405
Testing effectiveness (Phase 2)Study completedNCT02405013
What this trial is testing

Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa

Who this might be right for
Hepatitis CHIV Infection
ANRS, Emerging Infectious Diseases 120
Large-scale testing (Phase 3)Study completedNCT02252016
What this trial is testing

Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 159
Testing effectiveness (Phase 2)WithdrawnNCT01157975
What this trial is testing

Study the Relationship Between Obesity and Hepatitis C Replication

Who this might be right for
Hepatitis C
University of California, San Diego
Large-scale testing (Phase 3)Study completedNCT01006031
What this trial is testing

Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

Who this might be right for
Liver CirrhosisHepatitis C VirusHIV Infection
Sociedad Andaluza de Enfermedades Infecciosas 25
Not applicableUnknownNCT03407703
What this trial is testing

Hepatitis C (HCV) Cure and Kidney Health

Who this might be right for
Hepatitis C
San Francisco Veterans Affairs Medical Center 50
Large-scale testing (Phase 3)Study completedNCT02738138
What this trial is testing

Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 153
Large-scale testing (Phase 3)Study completedNCT01783678
What this trial is testing

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

Who this might be right for
Chronic Hepatitis CHuman Immunodeficiency Virus
Gilead Sciences 275
Testing effectiveness (Phase 2)Study completedNCT02647632
What this trial is testing

Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir

Who this might be right for
Hepatitis C
ANRS, Emerging Infectious Diseases 26
Post-approval studies (Phase 4)Study completedNCT01429792
What this trial is testing

A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,013
Not applicableStudy completedNCT03341871
What this trial is testing

Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 1,095
Large-scale testing (Phase 3)Study completedNCT01846832
What this trial is testing

TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection

Who this might be right for
Hepatitis C, ChronicInfection
Janssen-Cilag International NV 232
Testing effectiveness (Phase 2)Study completedNCT02278419
What this trial is testing

An Efficacy and Safety Study of a 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive and Experienced Participants With Chronic Genotype 4 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Janssen-Cilag International NV 63
Testing effectiveness (Phase 2)Study completedNCT02868242
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 19
Next Page